Breakthrough in cancer treatment

The therapy has already shown outstanding results in tests on prostate cancer and leukaemia sufferers, it has minimal side effects and iTt could be available within two years, its developers said Tuesday.

It fights cancer and, potentially, HIV/AIDS by boosting the body's immune system to make it produce more of the vital T-cells that produce thymus, the gland which shrinks naturally after puberty.

Tap Here to Add The Daily Star As A Trusted Source

The therapy is based on an existing class of drugs called GnRH analogues, which are used to block the production of sex hormones in people with prostate cancer, breast cancer and endometriosis.

It was developed by researchers at Melbourne's Monash University who discovered the GnRH analogues also acted to kick-start the T-cells.